share_log

上海谊众(688091.SH):《年产500万支注射用紫杉醇聚合物胶束及配套设施建设》募投项目获得建筑工程施工许可证

Shanghai Yizhong (688091.SH): “Construction of 5 million injectable paclitaxel polymer micelles and supporting facilities per year” has obtained a construction license for construction projects

Gelonghui Finance ·  Feb 4 02:39

Gelonghui, Feb. 4: Shanghai Yizhong (688091.SH) announced that it has recently obtained a “Construction Permit” issued by the Fengxian District Construction and Management Committee, marking that the “construction of 5 million injectable paclitaxel polymer micelles and supporting facilities per year” has entered the construction phase.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment